Solara Active Pharma Corporate Filings & Announcements

Latest corporate announcements and filings from Solara Active Pharma on BSE

Search Inside the pdf :

Solara Active Pharma Sciences Ltd.

09 Apr 2026

494.70

0.63%

Company Update

Solara Active Pharma Sciences Ltd - 541540 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026

pdf

Solara Active Pharma Sciences Ltd.

08 Apr 2026

494.70

0.63%

Company Update

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Solara Active Pharma Sciences Limited has informed the Exchange about the copy of Newspaper publication regarding the circulation of Second and Final Call Money Notice

pdf

Solara Active Pharma Sciences Ltd.

07 Apr 2026

494.70

0.63%

Company Update

Solara Active Pharma Sciences Ltd - 541540 - Intimation Regarding Dispatch Of The Second And Final …

BSE India

Solara Active Pharma Sciences Limited has intimated the Exchange regarding the completion of dispatch of Second and Final Call Money Notice to the eligible partly paid Rights Equity shareholders

pdf

Solara Active Pharma Sciences Ltd.

26 Mar 2026

494.70

0.63%

SAST

Solara Active Pharma Sciences Ltd - 541540 - Closure of Trading Window

BSE India

Intimation regarding closure of Trading Window for the quarter and year ended March 31, 2026

pdf

Solara Active Pharma Sciences Ltd.

25 Mar 2026

494.70

0.63%

Company Update

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Copy of the Newspaper Publication with respect to Record Date intimation for Second & Final Call on Rights Equity Shares

pdf

Solara Active Pharma Sciences Ltd.

25 Mar 2026

494.70

0.63%

Company Update

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper advertisement published regarding the special window for Re-lodgement of Transfer requests of physical shares by the shareholders.

pdf

Solara Active Pharma Sciences Ltd.

24 Mar 2026

494.70

0.63%

Company Update

Solara Active Pharma Sciences Ltd - 541540 - General Update - Rights Issue - Second & …

BSE India

Solara Active Pharma Sciences Limited has informed the exchange that the Rights Issue Committee members at its meeting held on March 24, 2026, has approved the making of Second and Final call of Rs. 112.50/- per equity shares (Rs. 3/- towards face value and Rs. 109.50/- towards securities premium) per rights shares in respect of Partly paid rights shares and fixed the Record date as April 02, 2026 for the same.

pdf

Solara Active Pharma Sciences Ltd.

24 Mar 2026

494.70

0.63%

Corp. Action

Solara Active Pharma Sciences Ltd - 541540 - Corporate Action- Record Date For The Purpose Of …

BSE India

Solara Active Pharma Sciences Limited has fixed April 02, 2026, as the record date for the purpose of making second and final call for the shares issued on the Rights basis.

pdf

Solara Active Pharma Sciences Ltd.

24 Mar 2026

494.70

0.63%

Board Meeting

Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Outcome for Outcome Of The Rights …

BSE India

Solara Active Pharma Sciences Limited has informed the Exchange that the Rights issue committee members at its meeting held on March 24, 2026, has approved the making of Second & Final call of ? 112.50/- per equity shares (? 3.00/- towards face value and ? 109.50/- towards securities premium) per Rights Share in respect of partly paid Rights Shares and Fixed the Record date as April 02, 2026 for the same.

pdf

Solara Active Pharma Sciences Ltd.

19 Mar 2026, 05:46PM

494.70

0.63%

Board Meeting

Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Intimation for Prior Intimation Of Meeting …

BSE India

Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 ,inter alia, to consider and approve the second & final Call and fixation of Record date by the Rights Issue Committee at their Meeting.

pdf

Is Solara Active Pharma Sciences Ltd. worth buying?

184 Votes:

Buy 80.43%

Sell 13.59%

Hold 5.98%